Choline Bitartrate Market Research, 2031
The global choline bitartrate market size was valued at $410.2 million in 2021, and is projected to reach $736.2 million by 2031, growing at a CAGR of 6.1% from 2022 to 2031.
Choline bitartrate is a combination of choline and a tartaric acid salt. It absorbs significantly better than pure choline, which is a vital human nutrition. Choline is chemically connected to the vitamin B group. Choline bitartrate and other choline supplements are said to increase athletic performance, lower cholesterol, protect the liver from the effects of alcohol, lower blood pressure, moderate mood swings, improve memory, and treat Alzheimer's disease. Increase in investment in chemicals and their usage surge demand from pharmaceutical & health care, food & beverages, and baby products industry. This is expected to drive the choline bitartrate market growth during the choline bitartrate market forecast period.
Rise in demand for infant formula, increased demand for fortified food & beverages, and various health benefits of choline bitartrate are the major factors that drive the growth of the global choline bitartrate market. In addition, increase in awareness concerning essential nutrition and rise in inclination toward preventive health care are anticipated to surge the demand for choline bitartrate in the near future. Rise in inclination toward natural food products along with stringent regulation for manufacturing infant formula pose as the major challenge for industry growth.
The choline bitartrate industry is classified into type, application, and region. On the basis of type, the market is segmented into DL, D, and L. On the basis of application, the market is divided into pharmaceutical & nutritional supplement, food & beverage, baby food, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Among the regions, North America held the highest share of the global choline bitartrate market in 2021 owing to increase in demand for baby food and infant formula products. Further, the rise in sales of dietary supplements owing to the hectic routines and stress level of the consumers is anticipated to propel the choline bitartrate market growth during the forecast period.
The key players operating in the global choline bitartrate market include Balchem Inc.; Celtic Chemicals Ltd; Cepham Life Sciences; Fengchen Group Co.,Ltd; Glentham Life Sciences Ltd; MP Biomedicals; Nutragreenlife Biotechnology Co.,Ltd; NutriScience Innovations, LLC; Puyer Group; and TOKYO CHEMICAL INDUSTRY CO., LTD. These companies compete for the share of the market through product launch, joint venture, partnership, and expansion of the production capabilities. For instance, Balchem Inc. announced that the company achieved Non-GMO Project Verification for the VitaCholine brand choline chloride and choline bitartrate ingredient product lines. These certifications are a mark of high quality, safety and transparency in production of the products.
On the basis of type, the L segment dominated the global choline bitartrate market share in terms of revenue, in 2021, owing to developments in the pharmaceuticals and nutraceuticals industry worldwide. L is widely used in the production of tablets, capsules, and powders. It is used in the pharmaceuticals and nutraceuticals industry owing to increase in absorption rate, and maintenance of cellular structure.
On the basis of application, the pharmaceutical & nutritional supplement segment dominated the global choline bitartrate market in terms of revenue, in 2021, owing to presence of aging population, rise in interest in preventive healthcare, and surge in interest in achieving wellness via healthy food.
By region, North America dominated the market with the highest revenue share in 2021 owing to increase in demand for baby food and infant formula products. This growth in demand is attributed to increase in disposable incomes, new product innovations, and high birth rate. In addition, surge in working women populace, easy availability, and inability to breastfeed boost the demand for baby food and infant formula products.
The COVID-19 pandemic has increased demand for choline bitartrate from a wide range of end-use sectors, including pharmaceuticals, dietary supplements, baby food, and animal feed, favorably impacting the global choline bitartrate market. After the development of COVID-19, sales of dietary supplements advertised for immune health increased because many individuals thought that these items might give some protection from SARS-CoV-2 infection and, for those who developed COVID-19, help lessen illness severity. Therefore, the above mentioned factors are predicted to surge the demand for choline bitartrate globally during the COVID-19 pandemic.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the choline bitartrate market analysis from 2021 to 2031 to identify the prevailing choline bitartrate market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the choline bitartrate market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global choline bitartrate market trends, key players, market segments, application areas, and market growth strategies.
Choline bitartrate Market Report Highlights
Key Market Players
Cepham Life Sciences, Puyer Group, Balchem Inc., Fengchen Group Co.,Ltd, NutriScience Innovations, LLC, MP Biomedicals, Glentham Life Sciences Ltd, TOKYO CHEMICAL INDUSTRY CO., LTD., Nutragreenlife Biotechnology Co.,Ltd, Celtic Chemicals Ltd
According to the opinions of various CXOs of leading companies, the choline bitartrate market is driven by health benefits associated with choline bitartrate and rise in demand for infant formula and dietary supplements.
Moreover, the North America region is projected to register a robust growth owing to increase in demand for baby food and infant formula products. This growth in demand is attributed to increase in disposable incomes, new product innovations, and high birth rate. In addition, rise in working women populace, easy availability and inability to breastfeed boost the demand for baby food and infant formula products.
Further, the presence of large number of manufacturers such as Balchem Inc.; Cepham Life Sciences, and NutriScience Innovations, LLC; and others, is driving the market growth in the region. However, rise in inclination toward natural food products along with stringent regulation for manufacturing infant formula are anticipated to hamper the market growth.